Individual sensititivy for the development of interstitial lung diseases (ILD)

Individual sensititivy for the development of interstitial lung diseases (ILD) - Individual sensitivity for interstitial lung diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33852

Enrollment

100

Registered

2008-08-20

Start date

2008-09-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic inflammatory lung diseases lung fibrosis sarcoidosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: ILD diagnosis confirmed by lung biopsy, X ray or BALF analysis

Exclusion criteria

Exclusion criteria: smoking pregnancy or lactation use of vitamins or nutritional supplements

Design outcomes

Primary

Measure	Time frame
differences in the production of and the protection against ROS differences in the occurring inflammatory reaction	—

Secondary

Measure	Time frame
differences in the presence of so-called volatile organic compounds (VOCs) in the exhaled air	—

Countries

Netherlands

Outcome results